Keywords: ایمونوتراپی تومور; Tumor immunotherapy; Antitumor immune response; Immunosuppression; Nanoparticles; Nanovaccines; Artificial antigen presenting cells; Targeting to immunosuppressive cells;
مقالات ISI ایمونوتراپی تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی تومور; Veterinary oncology; Tumor immunotherapy; Tumor immunology; DNA vaccine; Xenogeneic DNA vaccine; Monoclonal antibody;
Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma
Keywords: ایمونوتراپی تومور; Imiquimod; Dendritic cell vaccine; Tumor immunotherapy; Regulatory T cells (Treg); Mast cells;
Mini-reviewMHC class II restricted neoantigen: A promising target in tumor immunotherapy
Keywords: ایمونوتراپی تومور; MHC class II restricted neoantigen; CD4+ T cell; Tumor vaccine; Adoptive cell transfer; TCR-T cell; Tumor immunotherapy; mAb; monoclonal antibody; BiTE; bispecific T cell engager; ACT; adoptive cell transfer; TAs; tumor antigens; CTA; cancer-testis Ag; TI
A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy
Keywords: ایمونوتراپی تومور; Tumor associated macrophages; Regulatory T cells; Jak2-STAT3 pathway; Tumor immunotherapy; DMSO (PubChem CID: 679); DAPI (PubChem CID: 2954); PMA (PubChem CID: 27924); Lipopolysaccharides (PubChem CID: 53481793); Sodium citrate anticoagulant (PubChem CID:
Pharmacokinetics and bioavailability of tuftsin-derived T peptide, a promising antitumor agent, in beagles
Keywords: ایمونوتراپی تومور; Tumor immunotherapy; Tuftsin derivative; Antitumor agent; Pharmacokinetics; Bioavailability; T peptide;
Fully human monoclonal antibodies to TRAIL-R1 enhance TRAIL-induced apoptosis via activation of caspase-8 pathway
Keywords: ایمونوتراپی تومور; TRAIL; TRAIL-R1; Fully human monoclonal antibodies to TRAIL-R1; Apoptosis; Tumor immunotherapy; TRAIL; Tumor necrosis factor-related apoptosis-inducing ligand; TRAIL-R; TRAIL receptors; TR1-mAbs; monoclonal antibodies against TRAIL-R1; E-TR1-Ab; Enhancing
Enhancing adoptive T cell immunotherapy with microRNA therapeutics
Keywords: ایمونوتراپی تومور; Microrna (miRNA); Tumor immunotherapy; Adoptive cell transfer; T cell differentiation; CD8+ T cells;
The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation
Keywords: ایمونوتراپی تومور; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplantation; CFSE; carboxyfluorescein diacetate succinimidyl ester; FBS; fetal bovine serum; GVT; Graft-versus-tumor; GVHD; Graft-versus-host disease; GVL; graft-versus-leukemia; HAT; hypoxanthin
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Keywords: ایمونوتراپی تومور; BCG; Bacillus Calmette-Guérin; BMDC; bone marrow-derived dendritic cell; CTA; cancer/testis antigen; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T lymphocyte antigen-4; DC; dendritic cell; DNA; deoxyribonucleic acid; DTH; delayed-type hypersensitivity
A novel synthetic bipartite carrier protein for developing glycotope-based vaccines
Keywords: ایمونوتراپی تومور; Glycotope; Carrier protein; Vaccine; Tumor immunotherapy; Tn antigen;
Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model
Keywords: ایمونوتراپی تومور; Cell therapy; FoxP3; Synthetic oligodeoxynucleotides; Tumor immunotherapy
Targeting immune suppressing myeloid-derived suppressor cells in oncology
Keywords: ایمونوتراپی تومور; Myeloid-derived suppressor cells; Sunitinib; Stem cell factor (c-kit); Radiation therapy; Tumor immunotherapy; T regulatory cells
ReviewImmunotherapeutic modulation of the suppressive liver and tumor microenvironments
Keywords: ایمونوتراپی تومور; Tumor-associated macrophages; Myeloid derived suppressor cells; Regulatory dendritic cells; Regulatory T cells; Tumor immunotherapy; Liver microenvironment;
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells
Keywords: ایمونوتراپی تومور; Bispecific antibody-derivatives; CD19; Fcγ receptor; Natural killer cells; Tumor immunotherapy
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Keywords: ایمونوتراپی تومور; Tumor immunotherapy; Agonistic anti-CD40; CpG oligonucleotides; Localized biodistribution; Liposome delivery; Reduced toxicity
Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy
Keywords: ایمونوتراپی تومور; Listeria monocytogenes; Salmonella enterica; Tumor immunotherapy; Tumor-associated antigens; Tumor vasculature
Tandem-epitope peptide: A novel stimulator for γδT cells in tumor immunotherapy
Keywords: ایمونوتراپی تومور; γδT cells; Epitope; Peptide; Tumor immunotherapy
IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments
Keywords: ایمونوتراپی تومور; Tumor immunotherapy; T cells; Interleukin-12; Liposomes; SCID mice
Multipotency of CD11bhighGr-1+ immature myeloid cells accumulating in oral squamous cell carcinoma-bearing mice
Keywords: ایمونوتراپی تومور; Oral squamous cell carcinoma; Immature myeloid cells; Immune suppression; Tumor immunotherapy
Anti-CTLA4 antibody clinical trials in melanoma
Keywords: ایمونوتراپی تومور; Melanoma; Tumor immunotherapy; CTLA4; Tremelimumab; Autoimmunity; Monoclonal antibodies
The current status and future direction of percutaneous peptide immunization against melanoma
Keywords: ایمونوتراپی تومور; DC; dendritic cell; LC; Langerhans cell; Th; T helper; CTL; cytotoxic T lymphocytes; Treg; regulatory T; NK; natural killer; IL; interleukin; TGF; transforming growth factor; TNF; tumor necrosis factor; HLA; human leukocyte antigen; TAA; tumor-associatd a
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Keywords: ایمونوتراپی تومور; Dendritic cells; Tumor immunotherapy; Viral vectors; c-erbB-2; Alphaviruses
Potential use of CpG ODN for cancer immunotherapy
Keywords: ایمونوتراپی تومور; CpG ODN; Toll-like receptor (TLR); TLR9; Tumor immunotherapy
Tumor immune evasion mediated by IDO
Keywords: ایمونوتراپی تومور; Indoleamine 2,3-dioxygenase; Tryptophan; Tolerance; Regulatory T cells; Chemotherapy; TLR9 ligands; CpG oligodeoxynucleotides; Cancer; Tumor immunotherapy